BR112012005158B8 - método e aparelho para avaliar um valor representando uma massa ou uma concentração ou um volume de uma substância compreendida por um tecido ou um fluido corpóreo de um paciente, controlador, dispositivo para tratar o sangue de um paciente, e, meio de armazenamento digital - Google Patents

método e aparelho para avaliar um valor representando uma massa ou uma concentração ou um volume de uma substância compreendida por um tecido ou um fluido corpóreo de um paciente, controlador, dispositivo para tratar o sangue de um paciente, e, meio de armazenamento digital

Info

Publication number
BR112012005158B8
BR112012005158B8 BR112012005158A BR112012005158A BR112012005158B8 BR 112012005158 B8 BR112012005158 B8 BR 112012005158B8 BR 112012005158 A BR112012005158 A BR 112012005158A BR 112012005158 A BR112012005158 A BR 112012005158A BR 112012005158 B8 BR112012005158 B8 BR 112012005158B8
Authority
BR
Brazil
Prior art keywords
patient
mass
concentration
evaluating
tissue
Prior art date
Application number
BR112012005158A
Other languages
English (en)
Portuguese (pt)
Other versions
BR112012005158A2 (pt
BR112012005158B1 (pt
Inventor
Velasco Nestor
Chamney Paul
Wabel Peter
Wieskotten Sebastian
Moissl Ulrich
Nier Volker
Original Assignee
Fresenius Medical Care Deutschland Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fresenius Medical Care Deutschland Gmbh filed Critical Fresenius Medical Care Deutschland Gmbh
Publication of BR112012005158A2 publication Critical patent/BR112012005158A2/pt
Publication of BR112012005158B1 publication Critical patent/BR112012005158B1/pt
Publication of BR112012005158B8 publication Critical patent/BR112012005158B8/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483—Physical analysis of biological material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters
    • A61M5/172—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters electrical or electronic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
    • A61B5/14542—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring blood gases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/48—Other medical applications
    • A61B5/4836—Diagnosis combined with treatment in closed-loop systems or methods
    • A61B5/4839—Diagnosis combined with treatment in closed-loop systems or methods combined with drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
    • A61B5/7235—Details of waveform analysis
    • A61B5/7264—Classification of physiological signals or data, e.g. using neural networks, statistical classifiers, expert systems or fuzzy systems
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/60—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records
    • G16H10/65—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records stored on portable record carriers, e.g. on smartcards, RFID tags or CD
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/05—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves
    • A61B5/053—Measuring electrical impedance or conductance of a portion of the body
    • A61B5/0537—Measuring body composition by impedance, e.g. tissue hydration or fat content

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medical Informatics (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Surgery (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Primary Health Care (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Artificial Intelligence (AREA)
  • Vascular Medicine (AREA)
  • Anesthesiology (AREA)
  • Fuzzy Systems (AREA)
  • Physiology (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Mathematical Physics (AREA)
  • Evolutionary Computation (AREA)
  • Psychiatry (AREA)
  • Signal Processing (AREA)
  • Data Mining & Analysis (AREA)
BR112012005158A 2009-09-09 2010-09-07 método e aparelho para avaliar um valor representando uma massa ou uma concentração ou um volume de uma substância compreendida por um tecido ou um fluido corpóreo de um paciente, controlador, dispositivo para tratar o sangue de um paciente, e, meio de armazenamento digital BR112012005158B8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP09011550A EP2295097A1 (en) 2009-09-09 2009-09-09 Method and apparatus for evaluating values representing a mass or a concentration of a substance present within the body of a patient
EP09011550.2 2009-09-09
PCT/EP2010/005480 WO2011029569A1 (en) 2009-09-09 2010-09-07 Method and apparatus for evaluating values representing a mass or a concentration of a substance present within the body of a patient

Publications (3)

Publication Number Publication Date
BR112012005158A2 BR112012005158A2 (pt) 2016-05-03
BR112012005158B1 BR112012005158B1 (pt) 2020-12-29
BR112012005158B8 true BR112012005158B8 (pt) 2021-06-22

Family

ID=41319576

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112012005158A BR112012005158B8 (pt) 2009-09-09 2010-09-07 método e aparelho para avaliar um valor representando uma massa ou uma concentração ou um volume de uma substância compreendida por um tecido ou um fluido corpóreo de um paciente, controlador, dispositivo para tratar o sangue de um paciente, e, meio de armazenamento digital

Country Status (10)

Country Link
US (2) US9301716B2 (enExample)
EP (2) EP2295097A1 (enExample)
JP (1) JP5703528B2 (enExample)
KR (1) KR101861197B1 (enExample)
CN (1) CN102481102B (enExample)
AU (1) AU2010294525B2 (enExample)
BR (1) BR112012005158B8 (enExample)
CA (1) CA2773495C (enExample)
IN (1) IN2012DN02058A (enExample)
WO (1) WO2011029569A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9750862B2 (en) 2011-04-29 2017-09-05 Medtronic, Inc. Adaptive system for blood fluid removal
US9757591B2 (en) * 2013-02-11 2017-09-12 Bayer Healthcare Llc Methods and systems for monitoring an automated infusion system
US20150100009A1 (en) * 2013-10-09 2015-04-09 Medtronic, Inc. Surgical and Post Surgical Fluid Management
AU2015264323B2 (en) * 2014-05-20 2018-10-04 Fresenius Medical Care Holdings, Inc. Absolute blood volume measurement using ultrafiltration pulsing
EP3606440B1 (en) * 2017-04-04 2024-08-07 Cella Medical, Inc. Method and device for determining the hydration, fitness and nutrition status of a human body
CA3156801A1 (en) 2019-10-04 2021-04-08 Fresenius Medical Care Holdings, Inc. Techniques for determining patient blood characteristics during a dialysis process

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4895163A (en) 1988-05-24 1990-01-23 Bio Analogics, Inc. System for body impedance data acquisition
US5280429A (en) 1991-04-30 1994-01-18 Xitron Technologies Method and apparatus for displaying multi-frequency bio-impedance
JPH06218046A (ja) 1993-01-25 1994-08-09 Sanyo Electric Works Ltd 血液浄化装置
JPH1014899A (ja) * 1996-07-05 1998-01-20 Sekisui Chem Co Ltd 身体組成推計装置及び身体組成推計方法
US6010454A (en) * 1997-05-29 2000-01-04 Aquintel, Inc. Fluid and electrolyte balance monitoring system for surgical and critically ill patients
JP2002053209A (ja) * 2000-08-08 2002-02-19 Kentop:Kk 配置販売業における在庫管理装置および在庫管理方法
EP1205144B1 (en) * 2000-11-06 2002-10-02 Fresenius Medical Care Deutschland GmbH A method and a device for determining the dry weight of a patient with kidney failure
WO2002053209A1 (fr) * 2000-12-27 2002-07-11 Philips Japan, Ltd. Systeme de controle de l'information d'un dispositif de traitement sanguin et de l'information biologique, dispositif de controle de l'information d'un dispositif de traitement sanguin et de l'information biologique, et procede de commande correspondant
US7657292B2 (en) 2001-03-16 2010-02-02 Nellcor Puritan Bennett Llc Method for evaluating extracellular water concentration in tissue
US8135448B2 (en) * 2001-03-16 2012-03-13 Nellcor Puritan Bennett Llc Systems and methods to assess one or more body fluid metrics
US20040242977A1 (en) * 2003-06-02 2004-12-02 Dosmann Andrew J. Non-invasive methods of detecting analyte concentrations using hyperosmotic fluids
CN1960672B (zh) 2004-06-29 2010-05-12 弗雷森纽斯医疗护理德国有限责任公司 确定病人水合和/或营养状况的方法和装置
US7938817B2 (en) * 2004-09-09 2011-05-10 Plc Medical Systems, Inc. Patient hydration system and method
US8956291B2 (en) * 2005-02-22 2015-02-17 Admetsys Corporation Balanced physiological monitoring and treatment system
US8447376B2 (en) * 2006-10-04 2013-05-21 Dexcom, Inc. Analyte sensor
JP5529009B2 (ja) * 2007-05-14 2014-06-25 インぺディメッド リミテッド インジケータを用いるインピーダンス分析方法と分析装置
WO2009115944A1 (en) * 2008-03-17 2009-09-24 Philips Intellectual Property & Standards Gmbh Method and system for automatically controlling a physiological variable of a patient in a closed loop
US9370324B2 (en) * 2008-11-05 2016-06-21 Fresenius Medical Care Holdings, Inc. Hemodialysis patient data acquisition, management and analysis system

Also Published As

Publication number Publication date
IN2012DN02058A (enExample) 2015-08-21
KR20120062741A (ko) 2012-06-14
US10551370B2 (en) 2020-02-04
EP2475409B1 (en) 2020-10-28
CA2773495A1 (en) 2011-03-17
US20160169861A1 (en) 2016-06-16
US20130018245A1 (en) 2013-01-17
CN102481102A (zh) 2012-05-30
EP2295097A1 (en) 2011-03-16
AU2010294525B2 (en) 2015-09-17
WO2011029569A8 (en) 2011-06-30
WO2011029569A1 (en) 2011-03-17
EP2475409A1 (en) 2012-07-18
JP2013503727A (ja) 2013-02-04
US9301716B2 (en) 2016-04-05
AU2010294525A1 (en) 2012-04-05
CA2773495C (en) 2023-10-24
BR112012005158A2 (pt) 2016-05-03
KR101861197B1 (ko) 2018-05-25
CN102481102B (zh) 2015-11-25
JP5703528B2 (ja) 2015-04-22
BR112012005158B1 (pt) 2020-12-29

Similar Documents

Publication Publication Date Title
BR112013006764A2 (pt) método para avaliar um paciente, kit, meio legível por computador, método para avaliar um tratamento, método para avaliar o risco de um paciente, método para monitorar, método de diagnosticar, sistema de teste, método para classificar ou agrupar uma população de indivíduos, método para avaliar um desfecho substituto, método para tratar, uso de pelo menos um biomarcador, uso de um agente
EP4652923A3 (en) Apparatus for determining damaged tissue using sub-epidermal moisture measurements
MX352827B (es) Valoracion de la actividad de la ruta de señalizacion celular usando modelado probabilistico de la expresion del gen diana.
ZA201803207B (en) MR-proADM AS MARKER FOR THE EXTRACELLULAR VOLUME STATUS OF A SUBJECT
WO2014102668A3 (en) Assessment of cellular signaling pathway activity using linear combination(s) of target gene expressions;
WO2010082944A3 (en) Systems and methods for imaging changes in tissue
EP2376759A4 (en) DIAGNOSTIC PROCEDURE AND DEVICE FOR AN OUTLET PRESSURE REGULATOR
MX2012001716A (es) Marcadores biologicos para monitorizar la respuesta del paciente a los antagonistas vegf.
IL212675A0 (en) Disposable cassette and method of use for blood analysis on blood analyzer
BRPI0906903A2 (pt) ''anticorpo kit de diagnóstico, método de detecção da expressão de cd70 em uma amostra de tecido, método para prognosticar, determinar um protocolo de tratamento ou monitorar o tratamento, uso de um agente de ligação a cd70 e combinação de um kit de diagnóstico e um kit farmacêutico
NZ588853A (en) Compositions and methods for treating and diagnosing asthma
GB201007235D0 (en) Taz/wwtr1 for diagnosis and treatment of cancer
BR112014009233A2 (pt) sistema para a caracterização de pelo menos um parâmetro anatômico de uma via respiratória superior de um paciente pela análise de propriedades espectrais de um enunciado; uso de um sistema; e método para a avaliação de pelo menos um parâmetro anatômico de uma via respiratória superior de um paciente pela análise de propriedades espectrais de um enunciado
WO2011156734A3 (en) Method of characterizing vascular diseases
EP2503338A3 (en) CD73 as a biomarker for monitoring development of diseases and assessing the efficacy of therapies
WO2008070663A3 (en) Companion diagnostic assays for cancer therapy
WO2009122024A3 (fr) Dispositif et procede de micro-elastographie
EP2636034A4 (en) SYSTEM AND METHOD FOR ASSESSING OR IMPROVING MINIMALLY INVASIVE SURGICAL SKILLS
WO2011029569A8 (en) Method and apparatus for evaluating values representing a mass or a concentration of a substance present within the body of a patient
JP2013543581A5 (enExample)
JP2008528105A5 (enExample)
WO2013077814A3 (en) Natural-killer/t-cell lymphoma (nktcl) susceptibility prediction, diagnosis and therapy
WO2014153661A8 (en) Method for detecting and monitoring bone loss
IN2014MN01795A (enExample)
IN2013CN02996A (enExample)

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 29/12/2020, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 07/09/2010, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 16A ANUIDADE.